524
Participants
Start Date
October 31, 2000
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
Abatacept (BMS-188667)
IV, 10 mg/Kg, monthly, for the duration of the trial
Abatacept (BMS-188667)
Intravenous (IV) infusion, 2 mg/kg, infused intravenously for approximately 30 min, infusions on Days 1, 15, 30 and monthly thereafter for 12 months
Abatacept (BMS-188667)
Intravenous (IV) infusion, 10 mg/kg, infused intravenously for approximately 30 min, infusions on Days 1, 15, 30 and monthly thereafter for 12 months
Placebo
Intravenous (IV) infusion, 0 mg/kg, infused intravenously for approximately 30 min, infusions on Days 1, 15, 30 and monthly thereafter for 12 months
Local Institution, Birmingham
Local Institution, Huntsville
Local Institution, Long Beach
Local Institution, Highlands Ranch
Local Institution, Largo
Local Institution, Titusville
Local Institution, West Palm Beach
Local Institution, Rome
Local Institution, Chicago
Local Institution, Wichita
Local Institution, Cumberland
Local Institution, Springfield
Local Institution, Worcester
Local Institution, Duluth
Local Institution, Lincoln
Local Institution, Albuquerque
Local Institution, Los Alamos
Local Institution, Albany
Local Institution, Binghamton
Local Institution, The Bronx
Local Institution, Portland
Local Institution, Duncansville
Local Institution, Sellersville
Local Institution, Amarillo
Local Institution, Austin
Local Institution, Dallas
Local Institution, Buenos Aries
Local Institution, Quilmes
Local Institution, Adelaide
Local Institution, Malvern
Local Institution, Perth
Local Institution, Antwerp
Local Institution, Brussels
Local Institution, Ghent
Local Institution, Leuven
Local Institution, Mons
Local Institution, Edmonton
Local Institution, Ottawa
Local Institution, Toronto
Local Institution, Montreal
Local Institution, Sherbrooke
Local Institution, Ste-Foy
Local Institution, St. John's
Local Institution, Montpellier
Local Institution, Strasbourg
Local Institution, Paris
Local Institution, Berlin
Local Institution, Freiburg im Breisgau
Local Institution, Jena
Local Institution, Cork
Local Institution, Nijmegen
Local Institution, Muckleneuk
Local Institution, Cape Town
Local Institution, Cambridge
Local Institution, Manchester
Local Institution, Maidstone
Local Institution, Leeds
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY